2026 Annual Meeting | C172 - Trigeminal Neuralgia: Mimics, Pharmacotherapy, and Surgical/Interventional Treatment

Date Wednesday 04/22/26

Time 07:00 AM - 09:00 AM CDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Carrie Dougherty, MD

Topic(s) Headache

Learning Objectives Participants should gain an understanding of the pathophysiology of trigeminal neuralgia and potential neuroanatomical contributions; diagnostic features of trigeminal neuralgia; first- and second-line pharmacologic treatment options for trigeminal neuralgia; therapeutic options for treating breakthrough attacks; the characteristics of odontogenic pain; the differences between TMD and odontogenic pain with trigeminal neuralgia; the role of dentistry and the orofacial pain specialist in a multidisciplinary care model for trigeminal neuralgia; optimal interventional techniques used for the treatment of refractory trigeminal neuralgia; and optimal surgical techniques used for the treatment of trigeminal neuralgia.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Quality Improvement

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Case-based

Event Timeline
07:00 AM - 07:05 AM CDT	Introduction	Introduction Carrie Dougherty, MD
07:05 AM - 07:35 AM CDT	Speaker	Trigeminal Neuralgia: Pathophysiology, Diagnosis and Pharmacological Management of Trigeminal Neuralgia Carrie Dougherty, MD
07:35 AM - 08:05 AM CDT	Speaker	Trigeminal Neuralgia Mimics. Headache and Orofacial Pain Differential Diagnosis and Management Marcela Romero-Reyes, DDS, PhD
08:05 AM - 08:35 AM CDT	Speaker	Trigeminal Neuralgia: Surgical and Interventional Management Carrie E. Robertson, MD, FAAN
08:35 AM - 09:00 AM CDT	Q&A	Questions and Answers Carrie Dougherty, MD, Carrie E. Robertson, MD, FAAN, Marcela Romero-Reyes, DDS, PhD

Faculty Disclosures
Carrie Dougherty, MD	Dr. Dougherty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Dougherty has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Dougherty has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Dougherty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Dougherty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axsome. The institution of Dr. Dougherty has received research support from Eli Lilly and Co. The institution of Dr. Dougherty has received research support from AbbVie. The institution of Dr. Dougherty has received research support from Axsome. The institution of Dr. Dougherty has received research support from Lundbeck.
Carrie E. Robertson, MD, FAAN	Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Linpharma. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Satsuma. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Apeya. Dr. Robertson has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for UpToDate. The institution of Dr. Robertson has received research support from Biohaven/Pfizer. Dr. Robertson has received publishing royalties from a publication relating to health care. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving as a Research consultant with University of Minnesota.
Marcela Romero-Reyes, DDS, PhD	Marcela Romero-Reyes, DDS, PhD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Marcela Romero-Reyes, DDS, PhD has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Pain Medicine OUP.

��ɫ��

��ɫ��